-
-
Available Formats
- Options
- Availability
- Priced From ( in USD )
-
Available Formats
-
- Immediate download
- $60.00
- Add to Cart
-
- Printed Edition
- Ships in 1-2 business days
- $60.00
- Add to Cart
Customers Who Bought This Also Bought
-
ASTM C1316-08(2017)
Priced From $54.00 -
ASTM C1562-10(2018)
Priced From $69.00 -
ASTM C1533-15(2022)
Priced From $60.00 -
ASTM C967-20
Priced From $44.00
About This Item
Full Description
1.1 This practice covers the separation and preconcentration of neptunium-237 (237Np), thorium-232 (232Th), uranium-235 (235U) and uranium-238 (238U) from urine followed by quantitation using ICP-MS.
1.2 This practice can be used to support routine bioassay programs. The minimum detectable concentrations (MDC) for this method, taking the preconcentration factor into account, are approximately 1E-2Bq for 237Np (0.38ng), 2E-6Bq for 232Th (0.50ng), 4E-5Bq for 235U (0.50ng) and 6E-6Bq for 238U (0.48ng).
1.3 This standard does not purport to address all of the safety problems, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
Document History
-
ASTM C1614-05(2010)
viewing
Standard Practice for the Determination of 237Np, 232Th, 235U and 238U in Urine by Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Gamma Ray Spectrometry. (Withdrawn 2015)- Most Recent
-
ASTM C1614-05
Standard Practice for the Determination of 237Np, 232Th, 235U and 238U in Urine by Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Gamma Ray Spectrometry.- Historical Version